| 10009898 |
(−)-11-nor-9-carboxy-Δ9-THC-d3 (solution)
|
|
130381-15-6 |
≥99% deuterated forms (d1-d3)
|
|
|
2010-11-12
|
6.273825966850
|
-11-nor-9-carboxy-9-thc-d3-solution
|
|
THC metabolites Delta9-THC Δ9 THC tetrahydrocannabinols marijuana deuterateds deuterium internal standards mass spectrometry GC/MS LC/MS GC-MS LC-MS MS cannabinoids cbs synthetic 10916 |
6.273825966850
|
| 10009897 |
(−)-11-nor-9-carboxy-Δ9-THC (solution)
|
|
56354-06-4 |
≥98%
|
|
|
2010-11-11
|
6.639502762431
|
-11-nor-9-carboxy-9-thc-solution
|
|
THC metabolites Delta9-THC Δ9-THC tetrahydrocannabinols marijuana cannabinoids cbs synthetic 10915 |
6.639502762431
|
| 10010132 |
15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester
|
|
- |
≥98% (isomer mixture)
|
|
|
2008-06-09
|
26.555457335788
|
15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester
|
15-deoxy-Δ12,14-PGJ2-2-glycerol ester
|
PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic |
26.555457335788
|
| 14810 |
17-phenyl trinor Prostaglandin E2
|
|
38315-43-4 |
>98%
|
|
|
|
56.688241252302
|
17-phenyl-trinor-prostaglandin-e2
|
17-phenyl trinor PGE2
|
agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 |
56.688241252302
|
| 10004238 |
17-phenyl trinor Prostaglandin E2 serinol amide
|
|
- |
≥95%
|
|
|
2004-05-13
|
117.110243093922
|
17-phenyl-trinor-prostaglandin-e2-serinol-amide
|
17-phenyl trinor PGE2-SA
|
agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 analogs 17-phenyl-PGE2SA 17-phenyl-PGE2-SA amides cannabinoids Cbs sythetic |
117.110243093922
|
| 10004237 |
17-phenyl trinor Prostaglandin F2α serinol amide
|
|
- |
>98%
|
|
|
2004-03-15
|
7.416194751381
|
17-phenyl-trinor-prostaglandin-f2-serinol-amide
|
17-phenyl trinor PGF2α-SA; 17-phenyl trinor PGF2α serinol amide; Bimatoprost serinol amide
|
analogs agonists receptors 17-phenyl-PGF2.alpha.SA 17-phenyl-PGF2alphaSA 17-phenyl-PGF2a-SA prostaglandins cannabinoids CBs synthetic |
7.416194751381
|
| 362152 |
1-Arachidonoyl Glycerol-d5
|
|
- |
≥99% deuterated product
|
|
|
|
29.892113259668
|
1-arachidonoyl-glycerol-d5
|
1-AG-d5
|
deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids cannabinoids cbs synthetic |
29.892113259668
|
| 10008602 |
20-HETE Ethanolamide
|
|
- |
≥98%
|
|
|
2006-09-26
|
32.682062615101
|
20-hete-ethanolamide
|
20-hydroxy AEA; 20-hydroxy Arachidonoyl Ethanolamide
|
hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction ethanolamides cannabinoids cbs synthetic |
32.682062615101
|
| 10009962 |
2-(14,15-Epoxyeicosatrienoyl) Glycerol
|
|
848667-56-1 |
≥95%
|
|
|
2008-04-03
|
28.374088397789
|
2-14-15-epoxyeicosatrienoyl-glycerol
|
2-14,15-EG
|
2-AG CYP450 metabolism mitogens cancers kidneys endocannabinoids cannabinoids cbs synthetic |
28.374088397789
|
| 362162 |
2-Arachidonoyl Glycerol-d5
|
|
- |
≥99% deuterated product
|
|
|
|
46.147099447513
|
2-arachidonoyl-glycerol-d5
|
2-AG-d5
|
deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology cannabinoids cbs synthetic |
46.147099447513
|
| 362160 |
2-Arachidonoyl Glycerol-d8
|
|
- |
≥99% deuterated product
|
|
|
|
71.042030386740
|
2-arachidonoyl-glycerol-d8
|
2-AG-d8
|
deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology cannabinoids cbs synthetic |
71.042030386740
|
| 10918 |
(±)3-epi CP 47,497-C8-homolog
|
|
- |
≥98%
|
|
|
2011-05-06
|
12.267457068203
|
-3-epi-cp-47-497-c8-homolog
|
|
(±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13802 |
12.267457068203
|
| 13802 |
(±)3-epi CP 47,497-C8-homolog (solution)
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-08-04
|
11.371533840622
|
-3-epi-cp-47-497-c8-homolog-solution
|
|
(±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10918 |
11.371533840622
|
| 13140 |
4-(n-nonyl) Benzeneboronic Acid
|
|
256383-45-6 |
≥98%
|
|
|
2009-11-04
|
6.668687845304
|
4-n-nonyl-benzeneboronic-acid
|
|
fatty acids amide hydrolase FAAH endocannabinoids arachidonoyl ethanolamides AEA inhibitors inhibit monoacylglycerol lipase MAGL 2-arachidonoyl glycerol 2-AG 2AG 2 AG inhibition cannabinoids cbs synthetic |
6.668687845304
|
| 11093 |
4-Quinolone-3-Carboxamide Derivative
New |
|
1314230-69-7 |
≥98%
|
|
|
2012-01-30
|
128.388330263966
|
4-quinolone-3-carboxamide-derivative
|
|
CB1 CB2 cannabinoid CBs central peripheral receptors inverse agonists antinociception AM630 analgesic pain osteoporosis synthetic ligands mice analgesic AM 630 AM-630 |
128.388330263966
|
| 13803 |
(±)5-epi CP 55,940
|
|
- |
≥98%
|
|
|
2010-08-04
|
7.455193370166
|
-5-epi-cp-55-940
|
|
(±)-5-trans-CP 55,940 (±)-CP 55,940 cannabinoids analogs receptors pains analgesics by-products standards Δ9-THC delta-tetrahydrocannabidiol CP 55940 CP44950 CP-55940 CP55,940 |
7.455193370166
|
| 10005764 |
8-iso Prostaglandin F2α Ethanolamide
|
|
- |
>98%
|
|
|
2004-09-24
|
17.166390423573
|
8-iso-prostaglandin-f2-ethanolamide
|
8-Isoprostane Ethanolamide; 8-epi PGF2α Ethanolamide; 8-iso PGF2α Ethanolamide; iPF2α-III Ethanolamide
|
ethanolamides prostaglandins anandamides AEA COX-2 cox2 cyclooxygenases synthases isoprostanes 8-epi-PGF2alpha 8-iso-PGF2alpha arachidonoyl prostamides congeners decomposition standards non-enzymatic iPF2a-III PGHS2 PGHS-2 ethanolamines 714966-38-8 cannabinoids cbs sythetic |
17.166390423573
|
| 10005223 |
AM1172
|
|
251908-92-6 |
>98%
|
|
|
2004-09-01
|
25.692268262737
|
am1172
|
|
cannabinoids neurotransmitters inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids inhibits arachidonoyl ethanolamides reuptake FAAH-resistant amide hydrolases neuroscience neurochemistry cannabinoids cbs synthetic |
25.692268262737
|
| 9001055 |
AM1220
Exclusive New |
|
137642-54-7 |
≥98%
|
|
✓ |
2011-10-11
|
118.380461040369
|
am1220
|
[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-1-naphthalenyl-methanone
|
AM-2201 AM 2201 AM-1220 AM 1220 cannabinoids CB1 CB2 CBs receptors pains forensic science forensics |
118.380461040369
|
| 10010118 |
AM1241
|
|
444912-48-5 |
>97%
|
|
|
2007-08-29
|
104.824301021262
|
am1241
|
|
CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 cannabinoids cbs synthetic |
104.824301021262
|
| 11282 |
AM1248
Exclusive New |
|
335160-66-2 |
≥98%
|
|
✓ |
2012-02-06
|
128.785932020974
|
am1248
|
|
CBs cannabinoids synthetic agonist AM-1248 AMs 1248 forensic sciences receptors CB1 CB2 1-pentyl-3-(1-adamantoyl)indole AM679 AM-679 679 |
128.785932020974
|
| 10707 |
AM2201
Exclusive |
|
335161-24-5 |
≥98%
|
|
✓ |
2011-03-07
|
122.875871207581
|
am2201
|
|
cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM-2201 AM 2201 |
122.875871207581
|
| 10862 |
AM2201 2'-naphthyl isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-06
|
68.319292234126
|
am2201-2-naphthyl-isomer
|
|
AM-2201 AM 2201 cannabinoids CBs isomers AMs forensics sciences cannabimimetics CB1 CB2 receptors agonists spices synthetics |
68.319292234126
|
| 11193 |
AM2201 7-hydroxyindole metabolite
New |
|
- |
≥98%
|
|
|
2012-01-16
|
119.790823986937
|
am2201-7-hydroxyindole-metabolite
|
|
forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 metabolites urinary urine metabolism synthetic central peripheral |
119.790823986937
|
| 10706 |
AM2201-d5
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-05-16
|
41.327683482825
|
am2201-d5
|
|
cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards |
41.327683482825
|
| 9001031 |
AM2201 N-(2-fluoropentyl) isomer
New |
|
- |
≥95%
|
|
|
2011-12-15
|
125.960721783419
|
am2201-n-2-fluoropentyl-isomer
|
|
forensics AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 synthetic isomers fluorine pentyl chains synthetic central peripheral |
125.960721783419
|
| 9001030 |
AM2201 N-(3-fluoropentyl) isomer
New |
|
- |
≥98%
|
|
|
2011-11-22
|
95.664221144848
|
am2201-n-3-fluoropentyl-isomer
|
|
forensics AM-2201 AM 2201 isomers cannabinoids CBs receptors pain CBs CB1 CB2 |
95.664221144848
|
| 9001029 |
AM2201 N-(4-fluoropentyl) isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-08-11
|
65.690699556963
|
am2201-n-4-fluoropentyl-isomer
|
|
forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 central peripheral |
65.690699556963
|
| 10203 |
AM2201 N-(4-hydroxypentyl) metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
105.795305348014
|
am2201-n-4-hydroxypentyl-metabolite
|
|
AM-2201 AM 2201 cannabinoids cannabimimetic metabolites CB1 CB2 CBS receptors forensics synthetics smoking urinary urine potent synthetic |
105.795305348014
|
| 11008 |
AM2233
New |
|
444912-55-4 |
≥98%
|
|
|
2011-10-24
|
100.230828316970
|
am2233
|
|
769958-75-0 forensic science cannabinoid receptors CB1 agonists WIN 55,212-2 WIN 55212-2 radioligands neuroscience |
100.230828316970
|
| 71670 |
AM251
|
|
183232-66-8 |
>98%
|
|
|
|
76.381213014119
|
am251
|
|
cannabinoids receptors antagonists CB1 analogs selective SR-141716-A AM-251 SR141716A neuroscience neurochemistry endocrinology |
76.381213014119
|
| 13452 |
AM3102
Exclusive |
|
213182-22-0 |
≥98%
|
|
✓ |
2009-08-11
|
45.108392879067
|
am3102
|
KDS-5104
|
OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic |
45.108392879067
|
| 10006974 |
AM630
|
|
164178-33-0 |
≥98%
|
|
|
2009-02-09
|
47.163132289748
|
am630
|
Iodopravadoline
|
neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors |
47.163132289748
|
| 10567 |
AM694
Exclusive |
|
335161-03-0 |
≥95%
|
|
✓ |
2011-01-31
|
55.781724575096
|
am694
|
|
cannabinoids CB1 CB2 receptors pain JWH neuroscience AM-694 AM 694 |
55.781724575096
|
| 10870 |
AM694 3-iodo isomer
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-08-31
|
55.513620654394
|
am694-3-iodo-isomer
|
|
cannabinoids CBs cannabimimetic CB1 receptors agonists CB2 forensics sciences isomers AM 694 AM-694 synthetic analogs methanone indoles potent 3 iodo |
55.513620654394
|
| 10869 |
AM694 4-iodo isomer
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-06-21
|
29.220392980301
|
am694-4-iodo-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 pain spices forensics synthetic receptors agonists AM-694 AM 694 analogs neuroscience |
29.220392980301
|
| 10008617 |
Arachidonic Acid Leelamide
|
|
- |
≥95%
|
|
|
2006-09-27
|
13.333687845304
|
arachidonic-acid-leelamide
|
|
AA cannabinoids central peripheral CB1 CB2 CP55940 PDK pyruvates dehydrogenases kinases anti-inflammatory inflammation phospholipases PLA2 inhibits inhibitors inhibition cannabinoids cbs sythetic |
13.333687845304
|
| 10007904 |
Arachidonoyl-1-thio-Glycerol
Exclusive |
|
- |
>98%
|
|
✓ |
2006-01-24
|
18.352375690608
|
arachidonoyl-1-thio-glycerol
|
1-S-Arachidonoyl-1-mercapto-2,3-propanediol
|
cannabinoids monoacylglycerols monoglycerol monoglyceride anandamides fatty acids neurochemistry neuroscience chromogenic substrates lipases 2-arachidonoyls 2-AG agonists central CB1 nervous system CNS rat brains MGL hydrolyzes arachidonic acids thioesters analogs thiols DTNB Ellman's reagents yellow cannabinoids cbs synthetic |
18.352375690608
|
| 10011178 |
Arachidonoyl Ethanolamide-d4
|
|
946524-40-9 |
≥99% deuterated product
|
|
|
2008-03-04
|
35.926298342541
|
arachidonoyl-ethanolamide-d4
|
AEA-d4; Anandamide-d4
|
deuterium GC/MS internal isotopes standards ethanolamides LC/MS mass spectrometry cannabinoids fatty acids deuterated neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
35.926298342541
|
| 10180 |
Arachidonoyl Ethanolamide Phosphate
|
|
183323-26-4 |
>98%
|
|
|
2004-08-19
|
15.640524861879
|
arachidonoyl-ethanolamide-phosphate
|
AEA-P; Anandamide Phosphate
|
endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors fatty acids phosphates anandamides LPA lysophosphatidic ethanolamines ethanolamides cannabinoids cbs synthetic |
15.640524861879
|
| 62170 |
Arachidonoyl Serinol
|
|
183718-70-9 |
>98%
|
|
|
|
32.943646408840
|
arachidonoyl-serinol
|
|
endocannabinoids anandamides 2AG CB1 receptors neurochemistry neuroscience cannabinoids cbs synthetic |
32.943646408840
|
| 13823 |
AX 048
Exclusive |
|
873079-69-7 |
≥98%
|
|
✓ |
2010-09-15
|
9.193425414365
|
ax-048
|
|
Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids |
9.193425414365
|
| 10506 |
Bio-active Lipid I Screening Library (96-Well)
|
|
- |
|
|
|
2010-06-15
|
44.241464088397
|
bio-active-lipid-i-screening-library-96-well
|
|
vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandins HTS high thoroughput screening cannabinoids cbs synthetic |
44.241464088397
|
| 90080 |
Cannabidiol
|
|
13956-29-1 |
>99%
|
|
|
|
26.647332280978
|
cannabidiol
|
CBD
|
delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids |
26.647332280978
|
| 13285 |
Cannabidiol dimethyl ether
|
|
1242-67-7 |
≥98%
|
|
|
2009-05-19
|
12.557320441989
|
cannabidiol-dimethyl-ether
|
Cannabidiol-2',6'-dimethyl ether; CBDD
|
15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic |
12.557320441989
|
| 90081 |
Cannabidiol (solution)
|
|
13956-29-1 |
≥99%
|
|
|
2011-03-03
|
33.602882973380
|
cannabidiol-solution
|
CBD
|
delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids |
33.602882973380
|
| 10508 |
Cannabinoid Agonist Screening Library (96-Well)
|
|
- |
|
|
|
2011-05-05
|
3.314917127072
|
cannabinoid-agonist-screening-library-96-well
|
|
plates screening cannabinoids CBs libraries
foresnics JWHs JWH-108 JWH-200 HU 210 CPs |
3.314917127072
|
| 71652 |
CAY10401
|
|
288862-89-5 |
>98%
|
|
|
2005-02-02
|
8.948825046040
|
cay10401
|
|
FAAH inhibitors analgesics fatty acids amides hydrolases inhibits inhibition hydrolysis hydrolyze CAY-10401 inactivation anandamides AEA arachidonoyl ethanolamides neuroscience neurochemistry cannabinoids cbs synthetic |
8.948825046040
|
| 10009523 |
CAY10429-d3
|
|
- |
≥99% deuterated product
|
|
|
2007-10-02
|
1.414364640884
|
cay10429-d3
|
Abnormal Cannabidiol-d3; Abn-CBD-d3
|
endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neurosciences cannabindoids CB1 CB2 deuterated deuterium mass spectrometry LC-MS GC-MS AbnCBD LC/MS GC/MS cannabinoids cbs synthetic |
1.414364640884
|
| 10008669 |
CAY10508
|
|
878533-35-8 |
>98%
|
|
|
2006-08-04
|
27.353314917127
|
cay10508
|
|
1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 cannabinoids cbs synthetic |
27.353314917127
|
| 10010398 |
CB-13
|
|
432047-72-8 |
≥98%
|
|
|
2009-06-30
|
30.332404939876
|
cb-13
|
CRA-13
|
cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 |
30.332404939876
|
| 10006590 |
CB1 Receptor (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
2005-05-10
|
58.365460405156
|
cb1-receptor-c-term-polyclonal-antibody
|
Cannabinoid Receptor 1
|
cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB IHC immunohistochemistry neuroscience neurochemistry endocrinology immunoblotting cannabinoids cbs synthetic |
58.365460405156
|
| 10010116 |
CB-25
Exclusive |
|
869376-63-6 |
>98%
|
|
✓ |
2007-10-25
|
16.706774861878
|
cb-25
|
|
cannabinoids ligands receptors CB1 CB2 THC anandamides AEA inverse agonists cannabinoids cbs synthetic |
16.706774861878
|
| 10010117 |
CB-52
Exclusive |
|
869376-90-9 |
≥98%
|
|
✓ |
2007-10-25
|
16.798142265193
|
cb-52
|
|
cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists cannabinoids cbs synthetic |
16.798142265193
|
| 13289 |
CB-86
Exclusive |
|
1150586-64-3 |
≥98%
|
|
✓ |
2010-05-03
|
17.649021310181
|
cb-86
|
|
cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione
6-Azauridine 6 Azauridine
Azauridine cannabinoids cbs synthetic |
17.649021310181
|
| 10917 |
(−)-CP 47, 497
|
|
114753-51-4 |
≥98%
|
|
|
2011-05-05
|
14.108511156878
|
-cp-47-497
|
|
cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 13218 |
14.108511156878
|
| 10910 |
(+)-CP 47,497
|
|
134308-14-8 |
≥98%
|
|
|
2011-05-05
|
13.627848173453
|
-cp-47-497
|
|
cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids |
13.627848173453
|
| 10913 |
(±)-CP 47,497
|
|
70434-82-1 |
≥98%
|
|
|
2011-05-05
|
29.260334883041
|
-cp-47-497
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 16851 |
29.260334883041
|
| 9000774 |
(±)-CP 47,497 C-7-hydroxy metabolite
New |
|
- |
≥95%
|
|
|
2011-11-04
|
147.044459984460
|
-cp-47-497-c-7-hydroxy-metabolite
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic metabolites herbal adulterant CP47,497 CP-47,497 |
147.044459984460
|
| 10908 |
(±)-CP 47,497-C8-homolog
Exclusive |
|
70434-92-3 |
≥98%
|
|
✓ |
2011-05-06
|
33.211843073581
|
-cp-47-497-c8-homolog
|
CAY10596; Cannabicyclohexanol
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic |
33.211843073581
|
| 9000773 |
CP 47,497-C8-homolog C-8-hydroxy metabolite
New |
|
- |
≥98%
|
|
|
2012-01-03
|
78.095627948632
|
cp-47-497-c8-homolog-c-8-hydroxy-metabolite
|
|
cannabinoids cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic CP-47497 CP 47,497 47,497 CPs CP47497 CP47,497 herbal blends CBs monophenols adulterant metabolites |
78.095627948632
|
| 10686 |
(±)-CP 47,497-C8-homolog-d7 (solution)
Exclusive |
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2011-03-14
|
21.771818898971
|
-cp-47-497-c8-homolog-d7-solution
|
Cannabicyclohexanol-d7
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 |
21.771818898971
|
| 13216 |
(±)-CP 47,497-C8-homolog (solution)
Exclusive |
|
70434-92-3 |
≥98%
|
|
✓ |
2009-04-23
|
43.502412536909
|
-cp-47-497-c8-homolog-solution
|
CAY10596; Cannabicyclohexanol
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 10908 |
43.502412536909
|
| 10687 |
(±)-CP 47,497-d11 (solution)
Exclusive |
|
- |
≥99% deuterated forms (d1-d11)
|
|
✓ |
2011-02-16
|
23.337757971923
|
-cp-47-497-d11-solution
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 |
23.337757971923
|
| 10889 |
CP 47,497-para-quinone analog
Exclusive |
|
- |
≥90%
|
|
✓ |
2011-07-13
|
13.459269521965
|
cp-47-497-para-quinone-analog
|
|
CP47,497 CP-47,497 analogs cannabinoids CBs forensics sciences quinones paraquinone CP47497 CP-47497 47497 47,497 cannabimimetics CB1 CB2 receptors agonists spices synthetics |
13.459269521965
|
| 13218 |
(−)-CP 47,497 (solution)
|
|
114753-51-4 |
≥98%
|
|
|
2009-04-13
|
16.635470743702
|
-cp-47-497-solution
|
|
cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 10917 |
16.635470743702
|
| 13219 |
(+)-CP 47,497 (solution)
|
|
134308-14-8 |
≥98%
|
|
|
2009-04-13
|
17.680171898900
|
-cp-47-497-solution
|
|
cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 10910 |
17.680171898900
|
| 16851 |
(±)-CP 47,497 (solution)
|
|
70434-82-1 |
≥98%
|
|
|
2008-12-10
|
40.643750448281
|
-cp-47-497-solution
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 10913 |
40.643750448281
|
| 90084 |
(−)-CP 55,940
|
|
83002-04-4 |
≥98%
|
|
|
2007-01-15
|
30.013067923302
|
-cp-55-940
|
|
CP 55940 CP-55940 CP-55,940 agonists cannabinoids CB1 CB2 THC receptors endocrinology cp55940 cp55,940 neurochemistry cbs synthetic |
30.013067923302
|
| 13608 |
(+)-CP 55,940
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-05-20
|
16.533217169570
|
-cp-55-940
|
|
Δ9-THC cannabinoids CB1 CB2 pain analgesic cannabinoids cbs synthetic |
16.533217169570
|
| 13241 |
(±)-CP 55,940
Exclusive |
|
83003-12-7 |
≥98%
|
|
✓ |
2009-05-20
|
24.597446286065
|
-cp-55-940
|
|
cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940 cbs synthetic |
24.597446286065
|
| 10007534 |
Docosahexaenoyl Ethanolamide
Exclusive |
|
162758-94-3 |
≥98%
|
|
✓ |
2006-02-17
|
22.962016574585
|
docosahexaenoyl-ethanolamide
|
DHEA; DEA
|
neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA |
22.962016574585
|
| 10964 |
Eicosapentaenoyl Ethanolamide
|
|
109001-03-8 |
≥98%
|
|
|
2011-06-22
|
40.873259668508
|
eicosapentaenoyl-ethanolamide
|
EPEA
|
cannabinoids CBSs endocannabinoids forensic sciences signals signaling N-acylethanolamide N-acylethanolamine NAE dietary restrictions lifespans TOR nematodes eicosapentaenoic acids inflammation anti-inflammatory |
40.873259668508
|
| 10919 |
(±)-epi CP 47, 497
|
|
- |
≥98%
|
|
|
2011-05-05
|
13.604473642789
|
-epi-cp-47-497
|
3-trans CP 47,497
|
(±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13801 |
13.604473642789
|
| 13801 |
(±)-epi CP 47,497 (solution)
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-08-04
|
11.620194114805
|
-epi-cp-47-497-solution
|
3-trans CP 47,497
|
(±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10919 |
11.620194114805
|
| 10004236 |
Fluprostenol serinol amide
|
|
- |
≥98%
|
|
|
2004-09-23
|
25.495878453039
|
fluprostenol-serinol-amide
|
Flu-SA
|
PGF2.alpha. PGF2alpha analogs agonists prostaglandins receptors amides cannabinoids CB1 CBs synthetic |
25.495878453039
|
| 10011357 |
Glycerophospho-N-Oleoyl Ethanolamine
Exclusive |
|
201738-24-1 |
≥98%
|
|
✓ |
2009-02-20
|
22.960773480663
|
glycerophospho-n-oleoyl-ethanolamine
|
|
cannabinoids neurotransmitter PPARs neurochemistry neuroscience fatty acids amides hydrolase oleoyl ethanolamides methabolism obesity nutrition diet NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic |
22.960773480663
|
| 10011356 |
Glycerophospho-N-Palmitoyl Ethanolamine
Exclusive |
|
100575-09-5 |
≥98%
|
|
✓ |
2009-03-12
|
11.982209944751
|
glycerophospho-n-palmitoyl-ethanolamine
|
GP-NPEA; GP-NAE
|
cannabinoids neurotransmitter neurochemistry neuroscience fatty acids amides hydrolase FAAHs palmitoyl ethanolamides inflammation anti-inflammatory C16:0 CBS NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic |
11.982209944751
|
| 10224 |
GPR55 Polyclonal Antibody
|
|
- |
|
|
|
2010-01-19
|
38.641258879242
|
gpr55-polyclonal-antibody
|
G Protein-Coupled Receptor 55
|
proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling cannabinoids cbs synthetic |
38.641258879242
|
| 10010372 |
GW 842166X
|
|
666260-75-9 |
≥98%
|
|
|
2008-05-23
|
35.737209944751
|
gw-842166x
|
|
inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic |
35.737209944751
|
| 10011038 |
Hemopressin
|
|
- |
|
|
|
2009-08-13
|
32.880710339384
|
hemopressin
|
|
peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic |
32.880710339384
|
| 90082 |
HU-210
|
|
112830-95-2 |
>98%
|
|
|
|
44.104514848065
|
hu-210
|
|
agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic |
44.104514848065
|
| 90083 |
HU-210 (solution)
|
|
112830-95-2 |
≥98%
|
|
|
2011-03-03
|
26.336929755327
|
hu-210-solution
|
|
agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic Tetrahydrocannabinol, Trans-(+-)-Isomer
Tetrahydrocannabinol, (6a-trans)-Isomer
Tetrahydrocannabinol (6aS-cis)-Isomer
Tetrahydrocannabinol (6aR-cis)-Isomer
Solvay Brand of Tetrahydrocannabinol
Tetrahydrocannabinol Trans-Isomer Tetrahydrocannabinol Trans Isomer delta(9)-Tetrahydrocannabinol
delta(1)-Tetrahydrocannabinol
9-ene-Tetrahydrocannabinol
9 ene Tetrahydrocannabinol
Tetrahydrocannabinol
delta(9)-THC delta(1)-THC Dronabinol Marinol THC |
26.336929755327
|
| 10005673 |
HU-331
|
|
137252-25-6 |
≥95%
|
|
|
2005-09-09
|
28.665938203397
|
hu-331
|
|
cannabidiols analogs antiproliferative activity endocannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology receptors memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation hydroxylquinone antineoplastic human cancer cells lines inhibits inhibitors inhibition growth Raji Jurkat lymphomas in vitro HT-29 colon carcinomas neuroscience neurochemistry cannabinoids cbs sythetic |
28.665938203397
|
| 10266 |
JWH 007
Exclusive |
|
155471-10-6 |
≥98%
|
|
✓ |
2011-02-23
|
39.806735761424
|
jwh-007
|
|
agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy JWHs CBs JWH-007 JWH007 JWH-7 JWH 7 JWH7 |
39.806735761424
|
| 10486 |
JWH 007-d9
|
|
- |
≥99% deuterated product
|
|
|
2010-10-11
|
42.265883416430
|
jwh-007-d9
|
|
agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 |
42.265883416430
|
| 9001058 |
JWH 011
Exclusive New |
|
155471-13-9 |
≥98%
|
|
✓ |
2011-09-06
|
35.616664171055
|
jwh-011
|
JWH 004 1-methylhexyl analog
|
JWH011 JWH-011 JWH11 JWH-11 JWH015 JWH-015 JWH15 JWH-15 JWHs analogs forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics central peripheral |
35.616664171055
|
| 10009018 |
JWH 015
|
|
155471-08-2 |
≥98%
|
|
|
2006-10-05
|
71.726170738024
|
jwh-015
|
|
agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic JWH15 JWH-15 JWH 15 |
71.726170738024
|
| 10660 |
JWH 015-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-21
|
49.700773480663
|
jwh-015-d7
|
|
agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 |
49.700773480663
|
| 10849 |
JWH 016
Exclusive |
|
155471-09-3 |
≥95%
|
|
✓ |
2011-07-13
|
46.194218095568
|
jwh-016
|
|
JWH016 JWH-016 cannabinoids CBs receptors isomers forensics sciences JWHs agonists cannabimimetics CB1 CB2 receptors agonists spices synthetics |
46.194218095568
|
| 10900 |
JWH 018
|
|
209414-07-3 |
≥98%
|
|
|
2011-05-05
|
39.860919038187
|
jwh-018
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 13169 |
39.860919038187
|
| 9000844 |
JWH 018 2-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-10-26
|
31.132379618776
|
jwh-018-2-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated cbs synthetic JWH-018 JWH018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
31.132379618776
|
| 10711 |
JWH 018 2-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-25
|
24.113084443524
|
jwh-018-2-hydroxyindole-metabolite-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
24.113084443524
|
| 9001004 |
JWH 018 2'-naphthyl isomer
Exclusive |
|
1131605-25-8 |
≥98%
|
|
✓ |
2011-06-20
|
41.582030283835
|
jwh-018-2-naphthyl-isomer
|
|
JWH018 JWH-018 CBs cannabinoids forensics sciences cannabimimetic CB1 CB2 receptors agonist spices synthetic |
41.582030283835
|
| 9001006 |
JWH 018 2'-naphthyl-N-(1,2-dimethylpropyl) isomer
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
22.875346781817
|
jwh-018-2-naphthyl-n-1-2-dimethylpropyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic herbal blends isomers JWH-018 JWH018 JWH18 JWH-18 18 |
22.875346781817
|
| 9001009 |
JWH 018 2'-naphthyl-N-(1-methylbutyl) isomer
|
|
- |
≥98%
|
|
|
2011-06-20
|
25.662569449162
|
jwh-018-2-naphthyl-n-1-methylbutyl-isomer
|
|
JWH018 JWH-018 CBs cannabinoids forensics sciences cannabimimetic CB1 CB2 receptor agonist spices synthetic |
25.662569449162
|
| 9001008 |
JWH 018 2'-naphthyl-N-(2,2-dimethylpropyl) isomer
|
|
- |
≥98%
|
|
|
2011-06-28
|
31.105322736730
|
jwh-018-2-naphthyl-n-2-2-dimethylpropyl-isomer
|
|
JWH-018 JWH018 JWH-18 JWH18 JWH 18 cannabinoids CBs forensics sciences cannabimimetics CB1 CB2 receptors agonists spices synthetics |
31.105322736730
|
| 9001010 |
JWH 018 2'-naphthyl-N-(2-methylbutyl) isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-13
|
27.775441093980
|
jwh-018-2-naphthyl-n-2-methylbutyl-isomer
|
|
JWH-018 JWH018 JWH 18 JWH18 JWH-18 forensics cbs cannabinoids isomers cannabimimetic CB1 CB2 receptors agoinsts spices synthetic pentyl chains herbal blends |
27.775441093980
|
| 9001005 |
JWH 018 2'-naphthyl-N-(3-methylbutyl) isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-13
|
26.411057887728
|
jwh-018-2-naphthyl-n-3-methylbutyl-isomer
|
|
JWHs isomers forensic science cannabinoids CBs JWH-018 JWH018 JWH18 JWH-18 CB1 CB2 receptors agonist spices synthetic |
26.411057887728
|
| 9000851 |
JWH 018 4-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
46.814097970685
|
jwh-018-4-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
46.814097970685
|
| 10712 |
JWH 018 4-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-25
|
33.195926243109
|
jwh-018-4-hydroxyindole-metabolite-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
33.195926243109
|
| 9000852 |
JWH 018 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
69.338314927368
|
jwh-018-5-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
69.338314927368
|
| 10713 |
JWH 018 5-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-11
|
27.502696454894
|
jwh-018-5-hydroxyindole-metabolite-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
27.502696454894
|
| 9000853 |
JWH 018 6-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
42.598628357426
|
jwh-018-6-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
42.598628357426
|
| 10714 |
JWH 018 6-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-25
|
47.737945073679
|
jwh-018-6-hydroxyindole-metabolite-d9
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
47.737945073679
|
| 10697 |
JWH 018 6-methoxyindole analog
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-02-15
|
30.978954958867
|
jwh-018-6-methoxyindole-analog
|
|
analogs metabolites cannabinoids receptors agonists CBs JWH-018 JWH018 JWH18 JWH-18 JWH 18 |
30.978954958867
|
| 9000854 |
JWH 018 7-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
37.179710050102
|
jwh-018-7-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
37.179710050102
|
| 10715 |
JWH 018 7-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-07-26
|
29.253143271526
|
jwh-018-7-hydroxyindole-metabolite-d9
|
|
WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
29.253143271526
|
| 9000799 |
JWH 018 adamantyl analog
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-07-18
|
40.803083811230
|
jwh-018-adamantyl-analog
|
AB-001
|
JWH 018 JWH-018 JWHs analogs forensics sciences cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics |
40.803083811230
|
| 13824 |
JWH 018-d9 (solution)
|
|
- |
≥99% deuterated product
|
|
|
2010-06-21
|
54.097431772776
|
jwh-018-d9-solution
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 |
54.097431772776
|
| 9001000 |
JWH 018 N-(1,1-dimethylpropyl) isomer
New |
|
- |
≥98%
|
|
|
2011-11-16
|
37.203630991269
|
jwh-018-n-1-1-dimethylpropyl-isomer
|
|
cannabinoids cannabimimetics CBs CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH018 JWH-018 JWH18 JWH 18 JWH-18 isomers herbal central peripheralpentyl chains |
37.203630991269
|
| 9001003 |
JWH 018 N-(1,2-dimethylpropyl) isomer
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
25.764946879970
|
jwh-018-n-1-2-dimethylpropyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic herbal blends isomers JWH-018 JWH018 JWH18 JWH-18 18 |
25.764946879970
|
| 9001002 |
JWH 018 N-(1-methylbutyl) isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-17
|
27.001535271697
|
jwh-018-n-1-methylbutyl-isomer
|
|
JWH-018 JWH018 CBs cannasbinoids forensic sciences cannabimimetic CB1 CB2 receptors agonist spices synthetic |
27.001535271697
|
| 9001001 |
JWH 018 N-(2,2-dimethylpropyl) isomer
|
|
- |
≥98%
|
|
|
2011-06-27
|
32.075737101371
|
jwh-018-n-2-2-dimethylpropyl-isomer
|
|
JWH018 JWH-018 JWH18 JWH-18 JWH 18 cannabinoids CBs forensics sciences cannabimimetics CB1 CB2 receptors agonists spices forensic synthetics |
32.075737101371
|
| 11119 |
(±)-JWH 018 N-(2-hydroxypentyl) metabolite
New |
|
- |
≥98%
|
|
|
2011-12-07
|
66.739667883151
|
-jwh-018-n-2-hydroxypentyl-metabolite
|
|
cannabinoids metabolites incense forensics urine urinary herbals JWHs JWH018 JWH-018 JWH 18 JWH18 JWH-18 serum alkyl cytochromes P450 CBs potent synthetic herbal blends CYP450 CYP-450 serum urine |
66.739667883151
|
| 10690 |
JWH 018 N-(2-methylbutyl) isomer
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-03-16
|
21.750250279686
|
jwh-018-n-2-methylbutyl-isomer
|
JWH 073 2-methylbutyl homolog
|
cannabinoids CBs receptors WIN 55,212-2 CB1 cannabimimetics analogs forensics standards JWH-073 JWH 73 JWH73 JWH-73 |
21.750250279686
|
| 11118 |
JWH 018 N-(3-hydroxypentyl) metabolite
New |
|
- |
≥98%
|
|
|
2011-11-17
|
44.999861027700
|
jwh-018-n-3-hydroxypentyl-metabolite
|
|
cannabinoids metabolites incense forensics urine urinary herbal CBs JWHs JWH018 JWH-018 JWH 18 JWH18 JWH-18 monohydroxylation alkyl chainscytochromes P450 serum |
44.999861027700
|
| 10691 |
JWH 018 N-(3-methylbutyl) isomer
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-02-07
|
25.015270666904
|
jwh-018-n-3-methylbutyl-isomer
|
JWH 073 3-methylbutyl homolog
|
cannabinoids agonist selective receptors WIN55212-2 WIN552122 WIN 55212-2 WIN 55,212-2 CB1 cannabimimetics analog forensics CBs JWH-073 JWH-73 JWH 73 JWH73 |
25.015270666904
|
| 11075 |
JWH 018 N-(4,5-epoxypentyl) analog
New |
|
- |
≥98%
|
|
|
2011-10-21
|
29.167137472777
|
jwh-018-n-4-5-epoxypentyl-analog
|
JWH 018 epoxide
|
cannabinoids CBs cannabimimetic CB1 CB2 receptor agonists spices forensics synthetic herbal central peripheral alkyl chains |
29.167137472777
|
| 10921 |
(−)-JWH 018 N-(4-hydroxypentyl) metabolite
New |
|
- |
≥98%
|
|
|
2011-12-07
|
63.986504246787
|
-jwh-018-n-4-hydroxypentyl-metabolite
|
|
cannabinoids CBs metabolites incense forensics urine urinary herbal blends JWHs JWH018 JWH-018 JWH 18 JWH-18 JWH18 enantiomers potent synthetic phase 1 phase I phase one glucuronidated enantiomer |
63.986504246787
|
| 10920 |
(+)-JWH 018 N-(4-hydroxypentyl) metabolite
New |
|
- |
≥98%
|
|
|
2011-12-07
|
70.342867883151
|
-jwh-018-n-4-hydroxypentyl-metabolite
|
|
cannabinoids CBs metabolites incense forensics urine urinary herbal blends JWHs JWH018 JWH-018 JWH 18 JWH-18 JWH18 enantiomers phase 1 phase I phase one metabolism enantiomer glucuronidated |
70.342867883151
|
| 10796 |
(±)-JWH 018 N-(4-hydroxypentyl) metabolite
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-05-31
|
44.595594023696
|
-jwh-018-n-4-hydroxypentyl-metabolite
|
|
JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures |
44.595594023696
|
| 10926 |
(±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5
Exclusive |
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2011-06-28
|
51.336977083511
|
-jwh-018-n-4-hydroxypentyl-metabolite-d5
|
|
JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures GC/MS deuteriums standards deuterateds LC/MS GC-MS LC-MS mass spectrometry |
51.336977083511
|
| 11047 |
JWH 018 N-(5-bromopentyl) analog
New |
|
- |
≥98%
|
|
|
2012-01-19
|
136.655819724129
|
jwh-018-n-5-bromopentyl-analog
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic central peripheral analogs JWH-018 JWH018 JWH 18 JWH18 JWH-18 JWHs herbal blends bromine pentyl chains |
136.655819724129
|
| 10521 |
JWH 018 N-(5-chloropentyl) analog
New |
|
- |
≥95%
|
|
|
2012-01-17
|
147.981840723864
|
jwh-018-n-5-chloropentyl-analog
|
|
cannabinoids CBs cannabimimetics CB1 CB2, receptors agonists spices forensics synthetic JWH018 JWH-018 JWH 18 JWH18 JWH-18 JWHs herbal blends analogs chlorine pentyl chains |
147.981840723864
|
| 9000855 |
JWH 018 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
111.610033422934
|
jwh-018-n-5-hydroxypentyl-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
111.610033422934
|
| 10933 |
JWH 018 N-(5-hydroxypentyl) metabolite-d5
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-06-22
|
79.757840793639
|
jwh-018-n-5-hydroxypentyl-metabolite-d5
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
79.757840793639
|
| 10958 |
JWH 018 N-(5-hydroxypentyl) β-D-Glucuronide
Exclusive New |
|
- |
≥95%
|
|
✓ |
2011-12-20
|
107.341983086389
|
jwh-018-n-5-hydroxypentyl-d-glucuronide
|
|
JWH-018 JWH018 JWH-18 JWH18 JWHs cannabinoids CBs forensics sciences conjugates metabolites glucuronide incense urine urinary herbal |
107.341983086389
|
| 9000856 |
JWH 018 N-pentanoic acid metabolite
Exclusive |
|
- |
≥95%
|
|
✓ |
2010-09-01
|
110.132510405829
|
jwh-018-n-pentanoic-acid-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
110.132510405829
|
| 9000867 |
JWH 018 N-pentanoic acid metabolite-d4
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-09-15
|
280.977045593935
|
jwh-018-n-pentanoic-acid-metabolite-d4
|
|
JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
280.977045593935
|
| 13169 |
JWH 018 (solution)
|
|
209414-07-3 |
≥98%
|
|
|
2009-03-12
|
68.923268613605
|
jwh-018-solution
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 10900 |
68.923268613605
|
| 13633 |
JWH 019
|
|
209414-08-4 |
≥98%
|
|
|
2010-01-14
|
50.127632658708
|
jwh-019
|
|
cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 |
50.127632658708
|
| 9000764 |
JWH 019 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-06
|
26.981218665814
|
jwh-019-5-hydroxyindole-metabolite
|
JWH 019-M2
|
JWH019 JWH-019 JWH-19 JWH 19 JWH19 cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetic smoking urinary urine serum neuroscience CBs |
26.981218665814
|
| 9000765 |
JWH 019 N-(6-hydroxyhexyl) metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-13
|
30.547854892471
|
jwh-019-n-6-hydroxyhexyl-metabolite
|
|
JWH019 JWH-019 JWH-19 JWH 19 JWH19 JWHs cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine serum herbal blends metabolized livers |
30.547854892471
|
| 10850 |
JWH 020
Exclusive |
|
209414-09-5 |
≥98%
|
|
✓ |
2011-06-02
|
43.933702363359
|
jwh-020
|
|
cannabinoids CBs cannabimimetic CB1 receptors agonists CB2 forensics bath salts JWH020 JWH-020 WIN55212-1 WIN55212-2 WIN-55212-1 WIN-55212-2 WIN552121 WIN552122 in vivo JWH 020 |
43.933702363359
|
| 9001056 |
JWH 022
Exclusive |
|
209414-16-4 |
≥98%
|
|
✓ |
2011-08-09
|
84.562414988077
|
jwh-022
|
|
JWH022 JWH-022 JWH22 JWH-22 JWHs cannabinoids CBs synthetic standards forensics sciences |
84.562414988077
|
| 10831 |
JWH 030
Exclusive New |
|
162934-73-8 |
≥98%
|
|
✓ |
2011-10-11
|
59.469825443952
|
jwh-030
|
|
JWH-030 JWH030 JWH30 JWH-30 JWH30 cannabimimetic cannabinoids synthetics CB1 CB2 CBs receptors forensics neuroscience naphtholyl pyrrole mouse mice inhibits inhibition inhibitors electrically induced vas deferens |
59.469825443952
|
| 10904 |
JWH 073
|
|
208987-48-8 |
≥97%
|
|
|
2011-05-06
|
40.353743785596
|
jwh-073
|
|
cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 |
40.353743785596
|
| 10633 |
JWH 073 2-hydroxyindole metabolite
|
|
- |
≥98%
|
|
|
2011-01-11
|
37.668238301845
|
jwh-073-2-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs JWH073 JWH-073 cannabinoids cbs synthetic JWH 73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
37.668238301845
|
| 10716 |
JWH 073 2-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-10
|
19.228790996521
|
jwh-073-2-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
19.228790996521
|
| 10848 |
JWH 073 2-methylnaphthyl analog
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
28.319358014608
|
jwh-073-2-methylnaphthyl-analog
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetics herbal blends JWH-073 073 JWH73 JWH-73 JWHs 73 |
28.319358014608
|
| 9001014 |
JWH 073 2'-naphthyl isomer
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-06-13
|
32.233909747710
|
jwh-073-2-naphthyl-isomer
|
|
JWHs isomers forensic sciences cannabinoids CBs JWH 73 JWH73 JWH-73 JWH073 JWH-073 cannabimimetic receptors Cb1 CB2 agonists spices synthetic herbal blends |
32.233909747710
|
| 9001016 |
JWH 073 2'-naphthyl-N-(1-methylpropyl) isomer
|
|
- |
≥98%
|
|
|
2011-06-28
|
36.495676592606
|
jwh-073-2-naphthyl-n-1-methylpropyl-isomer
|
|
JWH-073 JWH073 JWH-73 JWH73 JWH 73 cannabinoids CBs forensics sciences cannabimimetics CB1 CB2 receptors agonists spices synthetics |
36.495676592606
|
| 9001015 |
JWH 073 2'-naphthyl-N-(2-methylpropyl) isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-21
|
31.124385649001
|
jwh-073-2-naphthyl-n-2-methylpropyl-isomer
|
|
JWH-073 JWH073 JWH-73 JWH73 JWHs CBs cannabinoids forensic sciences cannabimimetic CB1 CB2 receptors agonists spices synthetic |
31.124385649001
|
| 9000861 |
JWH 073 4-hydroxyindole metabolite
|
|
- |
≥98%
|
|
|
2010-09-01
|
43.375395282530
|
jwh-073-4-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic standards CBs JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
43.375395282530
|
| 10717 |
JWH 073 4-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-21
|
19.579435563740
|
jwh-073-4-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
19.579435563740
|
| 9001076 |
JWH 073 4-methylnaphthyl analog
New |
|
- |
≥98%
|
|
|
2011-09-06
|
35.278436481376
|
jwh-073-4-methylnaphthyl-analog
|
JWH 122 N-butyl analog; 1-butyl-3-(1-(4-methyl)naphthoyl) indole
|
JWH073 JWH-073 JWH73 JWH-73 analogs hybrids forensics sciences cannabinoids CBs JWHs indoles cannabimimetics JWH 018 122 smoking incense spices forensics pains neuroscience |
35.278436481376
|
| 9000862 |
JWH 073 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
37.173574988467
|
jwh-073-5-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices cbs synthetic JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
37.173574988467
|
| 10718 |
JWH 073 5-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-11
|
21.566729128299
|
jwh-073-5-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
21.566729128299
|
| 9000863 |
JWH 073 6-hydroxyindole metabolite
Exclusive |
|
- |
≥95%
|
|
✓ |
2010-09-01
|
33.166485782090
|
jwh-073-6-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
33.166485782090
|
| 10719 |
JWH 073 6-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-11
|
19.228790996521
|
jwh-073-6-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
19.228790996521
|
| 9000864 |
JWH 073 7-hydroxyindole metabolite
Exclusive |
|
- |
98%
|
|
✓ |
2010-09-01
|
30.644219555686
|
jwh-073-7-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices synthetic JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
30.644219555686
|
| 10720 |
JWH 073 7-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-07-25
|
25.409004024282
|
jwh-073-7-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
25.409004024282
|
| 9000868 |
JWH 073-d7 (solution)
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-08-10
|
35.952230308723
|
jwh-073-d7-solution
|
|
deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 |
35.952230308723
|
| 9001013 |
JWH 073 N-(1,1-dimethylethyl) isomer
New |
|
- |
≥98%
|
|
|
2012-01-12
|
119.645204472316
|
jwh-073-n-1-1-dimethylethyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH073 JWH-073 central peripheral herbal blends butyl chains isomers |
119.645204472316
|
| 9001012 |
JWH 073 N-(1-methylpropyl) isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-22
|
34.836065991837
|
jwh-073-n-1-methylpropyl-isomer
|
|
JWH073 JWH-073 JWH73 JWH-73 forensics sciences cannabinoids CBs JWHs cannabimimetics CB1 CB2 receptors agonists spices synthetic |
34.836065991837
|
| 9001011 |
JWH 073 N-(2-methylpropyl) isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-21
|
28.791133147191
|
jwh-073-n-2-methylpropyl-isomer
|
|
JWH-073 JWH073 JWH-73 JWH73 JWHs CBs cannabinoids forensic sciences cannabimimetic CB1 CB2 receptors agonists spices synthetic |
28.791133147191
|
| 10795 |
(±)-JWH 073 N-(3-hydroxybutyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-05-31
|
53.345126292079
|
-jwh-073-n-3-hydroxybutyl-metabolite
|
|
JWH-073 JWH073 JWH73 JWH-73 JWH73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures |
53.345126292079
|
| 10927 |
(±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5
Exclusive |
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2011-07-25
|
46.084455221335
|
-jwh-073-n-3-hydroxybutyl-metabolite-d5
|
|
deuterateds deuterium GC-MS GC/MS LC-MS LC/MS mass spectrometry MS JWH073 JWH73 JWH-073 JWH-73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures pain neuroscience |
46.084455221335
|
| 9000865 |
JWH 073 N-(4-hydroxybutyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
85.111283486231
|
jwh-073-n-4-hydroxybutyl-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
85.111283486231
|
| 10934 |
JWH 073 N-(4-hydroxybutyl) metabolite-d5
Exclusive New |
|
- |
≥99% deuterated product
|
|
✓ |
2011-10-14
|
66.724011217090
|
jwh-073-n-4-hydroxybutyl-metabolite-d5
|
|
M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices |
66.724011217090
|
| 9000866 |
JWH 073 N-butanoic acid metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
94.707746633261
|
jwh-073-n-butanoic-acid-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices cbs synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
94.707746633261
|
| 9000870 |
JWH 073 N-butanoic acid metabolite-d5
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-09-20
|
88.435213297809
|
jwh-073-n-butanoic-acid-metabolite-d5
|
|
JWH 073 Metabolite 6-d5 JWH-073 JWH073 cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 deuterateds deuteriums mass spec GC-MS LC-MS GC/MS LC/MS M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
88.435213297809
|
| 13170 |
JWH 073 (solution)
|
|
208987-48-8 |
≥97%
|
|
|
2009-03-02
|
44.560786731709
|
jwh-073-solution
|
|
cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 |
44.560786731709
|
| 10579 |
JWH 081
|
|
210179-46-7 |
≥98%
|
|
|
2010-10-22
|
76.572986461864
|
jwh-081
|
|
cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids cbs synthetic JWH-081 JWH 81 JWH-81 JWH81 |
76.572986461864
|
| 9001044 |
JWH 081 2-methoxynaphthyl isomer
Exclusive New |
|
824960-76-1 |
≥98%
|
|
✓ |
2011-08-23
|
75.399601443297
|
jwh-081-2-methoxynaphthyl-isomer
|
JWH 267
|
JWH-081 JWH081 JWH-81 JWH81 JWHs isomers forensics sciences cannabinoids CBs JWH267 JWH-267 cannabimimetics CB1 CB2 receptors agonists spices synthetics |
75.399601443297
|
| 9001045 |
JWH 081 3-methoxynaphthyl isomer
New |
|
- |
≥98%
|
|
|
2012-01-25
|
187.336528974017
|
jwh-081-3-methoxynaphthyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH-081 JWH081 JWH81 JWH-81 JWH 81 central peripheral |
187.336528974017
|
| 9001046 |
JWH 081 5-methoxynaphthyl isomer
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
82.119364943219
|
jwh-081-5-methoxynaphthyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic JWH-081 JWH081 JWH-18 JWH48 18 isomers |
82.119364943219
|
| 9001047 |
JWH 081 6-methoxynaphthyl isomer
New |
|
824961-41-3 |
≥98%
|
|
|
2012-01-19
|
167.038438607436
|
jwh-081-6-methoxynaphthyl-isomer
|
JWH 166
|
cannabinoids CBs cannabimimetics central CB1 CB2 peripheral receptors agonists spices forensics synthetic isomers methoxy groups naphthyl rings research JWH081 JWH-081 JWH 81 JWH-81 JWH81 JWH166 JWH-166 JWHs |
167.038438607436
|
| 9001048 |
JWH 081 7-methoxynaphthyl isomer
Exclusive New |
|
824961-61-7 |
≥98%
|
|
✓ |
2011-10-11
|
69.521328910252
|
jwh-081-7-methoxynaphthyl-isomer
|
JWH 164
|
JWH 164 JWH164 JWH-164 cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic JWH-081 JWH081 JWH-81 JWH81 81 isomers |
69.521328910252
|
| 10511 |
JWH 081-d9
New |
|
- |
≥99% deuterated product
|
|
|
2011-09-08
|
66.443078325278
|
jwh-081-d9
|
|
cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS |
66.443078325278
|
| 9000768 |
JWH 081 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥95%
|
|
✓ |
2011-08-05
|
95.818200155193
|
jwh-081-n-5-hydroxypentyl-metabolite
|
|
JWH-081 JWH081 JWH-81 JWH81 JWH 81 JWHs CBs cannabinoids forensics sciences metabolites cannabimimetics metabolites CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum |
95.818200155193
|
| 10680 |
JWH 098
Exclusive |
|
316189-74-9 |
≥98%
|
|
✓ |
2011-04-20
|
51.161757491380
|
jwh-098
|
|
JWH-098 JWH98 JWH-98 JWH 98 cannabinoids cannabimimetics CBs CB1 receptors agonists CB2 pain spice forensics synthetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone 1-propyl-2-methyl-3-(1-naphthoyl)indole 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC 1-pentyl-3-(1-naphthoyl)indole naphthalenes JWH 133 JWH133 JWH-133 JWH-018 JWH018 JWH 018 JWH18 JWH015 JWH15 JWH 015 JWH-015 indoles |
51.161757491380
|
| 10591 |
JWH 122
|
|
619294-47-2 |
≥98%
|
|
|
2010-12-15
|
86.826609729501
|
jwh-122
|
|
JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs 1 2 CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids cbs synthetic |
86.826609729501
|
| 9001032 |
JWH 122 2-methylnaphthyl isomer
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-08-25
|
23.603525186488
|
jwh-122-2-methylnaphthyl-isomer
|
|
JWH-122 JWH122 JWHs isomers forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics |
23.603525186488
|
| 9001033 |
JWH 122 3-methylnaphthyl isomer
New |
|
- |
≥98%
|
|
|
2011-11-09
|
35.021365636895
|
jwh-122-3-methylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic synthetic herbal methyl naphthyl isomers JWH122 JWH-122 JWHs |
35.021365636895
|
| 9001034 |
JWH 122 5-methylnaphthyl isomer
New |
|
- |
≥98%
|
|
|
2011-11-09
|
35.021365636895
|
jwh-122-5-methylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH122 JWH-122 synthetic herbal methyl naphthyl isomers central peripheral |
35.021365636895
|
| 9001035 |
JWH 122 6-methylnaphthyl isomer
Exclusive New |
|
- |
≥95%
|
|
✓ |
2011-10-11
|
39.803660502447
|
jwh-122-6-methylnaphthyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetics herbal blends isomers JWH-122 JWH122 |
39.803660502447
|
| 9001036 |
JWH 122 7-methylnaphthyl isomer
Exclusive New |
|
824960-56-7 |
≥98%
|
|
✓ |
2011-10-11
|
33.349188957731
|
jwh-122-7-methylnaphthyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic herbal blends isomers JWH-122 JWH122 |
33.349188957731
|
| 9001037 |
JWH 122 8-methylnaphthyl isomer
New |
|
- |
≥98%
|
|
|
2011-11-30
|
53.893531714563
|
jwh-122-8-methylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic JWH-122 JWH122 herbalmethyl groups naphthyl rings herbal |
53.893531714563
|
| 10512 |
JWH 122-d9
New |
|
- |
≥99% deuterated product
|
|
|
2011-09-08
|
41.408151914141
|
jwh-122-d9
|
|
JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS |
41.408151914141
|
| 10925 |
JWH 122 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-17
|
50.501041928730
|
jwh-122-n-5-hydroxypentyl-metabolite
|
|
cannabinoids CBs receptors CB1 CB2 cannabimimetics analogs forensics JWH122 JWH-122 monohydroxylation N-alkyl chains naphthoylindole JWH 018 JWH018 JWH-018 JWH18 JWH-18 JWH 18 JWH073 JWH-073 JWH 073 JWH73 JWH-73 JWH 73 |
50.501041928730
|
| 10825 |
JWH 145
Exclusive New |
|
914458-19-8 |
≥95%
|
|
✓ |
2011-11-10
|
26.667005378671
|
jwh-145
|
|
JWH-145 JWH145 JWHs cannabinoids CBs CB1 CB2 herbals smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH018 JWH-018 JWH 018 blends 73 18 JWH073 JWH-073 JWH 073 JWH73 JWH 73 JWH-73 JWH18 JWH-18 |
26.667005378671
|
| 11201 |
JWH 175
Exclusive New |
|
619294-35-8 |
≥98%
|
|
✓ |
2012-02-09
|
130.536276661375
|
jwh-175
|
|
CBs JWH-175 JWH175 JWHs CB1 CB2 cannabinoids JWH018 JWH-018 JWH 018 receptors agonist spices synthetic |
130.536276661375
|
| 10643 |
JWH 182
Exclusive New |
|
824960-02-3 |
≥97%
|
|
✓ |
2011-10-11
|
53.435623815085
|
jwh-182
|
|
JWH-182 JWHs CB1 CB2 CBs receptors agonists pains spices forensics synthetics cannabinoids cells animals |
53.435623815085
|
| 10902 |
JWH 200
|
|
103610-04-4 |
≥98%
|
|
|
2011-05-05
|
47.054774727766
|
jwh-200
|
|
cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 |
47.054774727766
|
| 9000897 |
JWH 200 2'-naphthyl isomer
Exclusive |
|
133438-66-1 |
≥98%
|
|
✓ |
2011-06-20
|
22.689686475317
|
jwh-200-2-naphthyl-isomer
|
|
JWH200 JWH-200 CBs cannabinoids forensics sciences cannabimimetic CB1 receptors agonist spices synthetic |
22.689686475317
|
| 10744 |
JWH 200 4-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-04-15
|
36.781428004611
|
jwh-200-4-hydroxyindole-metabolite
|
|
JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine |
36.781428004611
|
| 10745 |
JWH 200 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-06
|
25.218674674828
|
jwh-200-5-hydroxyindole-metabolite
|
|
JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine neuroscience |
25.218674674828
|
| 10746 |
JWH 200 6-hydroxyindole metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
29.421324798993
|
jwh-200-6-hydroxyindole-metabolite
|
|
JWH200 JWH-200 cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetics smoking urinary urine aminoalkylindoles binds binding high-affinity high affinity JWHs |
29.421324798993
|
| 10747 |
JWH 200 7-hydroxyindole metabolite
New |
|
- |
≥98%
|
|
|
2011-11-21
|
28.707235708190
|
jwh-200-7-hydroxyindole-metabolite
|
|
JWH200 JWH-200 cannabinoids cannabimimetics metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine aminoalkylindole JWH 015 JWH 018 JWH015 JWH018 JWH-015 JWH-018 JWH15 JWH18 JWH 15 JWH 18 JWH-15 JWH-18 |
28.707235708190
|
| 10903 |
JWH 200-d5
|
|
- |
≥99% deuterated product
|
|
|
2011-05-06
|
10.563329852221
|
jwh-200-d5
|
|
cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 |
10.563329852221
|
| 10682 |
JWH 200-d5 (solution)
|
|
- |
≥99% deuterated product
|
|
|
2011-01-07
|
33.996941087390
|
jwh-200-d5-solution
|
|
cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 |
33.996941087390
|
| 13171 |
JWH 200 (solution)
|
|
103610-04-4 |
≥98%
|
|
|
2009-03-25
|
45.758690559580
|
jwh-200-solution
|
|
cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 |
45.758690559580
|
| 10721 |
JWH 201
Exclusive |
|
864445-47-6 |
≥98%
|
|
✓ |
2011-02-24
|
77.624510665918
|
jwh-201
|
|
cannabinoids CB1 CB2 receptors CBs JWH201 JWH-201 JWH250 JWH-250 JWH 250 |
77.624510665918
|
| 9000736 |
JWH 203
|
|
864445-54-5 |
≥98%
|
|
|
2011-02-21
|
73.687547154631
|
jwh-203
|
|
cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 cannabimimetics forensics pain CBs binding analgesic |
73.687547154631
|
| 10868 |
JWH 203 3-chlorophenyl isomer
Exclusive |
|
864445-56-7 |
≥98%
|
|
✓ |
2011-06-03
|
31.132707182320
|
jwh-203-3-chlorophenyl-isomer
|
JWH 237; JWH 203 3-chloro isomer
|
cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 CBs cannabimimetics forensics pain bath salts phenylacetylindole analog |
31.132707182320
|
| 10867 |
JWH 203 4-chlorophenyl isomer
Exclusive |
|
864445-58-9 |
≥98%
|
|
✓ |
2011-06-02
|
36.822909760589
|
jwh-203-4-chlorophenyl-isomer
|
JWH 206; JWH 203 4-chloro isomer
|
cannabinoids CB1 CB2 receptors synthetic forensics pain bath salts CBs JWH203 JWH-203 JWH206 JWH-206 |
36.822909760589
|
| 10644 |
JWH 210
|
|
824959-81-1 |
≥98%
|
|
|
2011-02-01
|
119.609337313713
|
jwh-210
|
|
cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 |
119.609337313713
|
| 9001038 |
JWH 210 2-ethylnaphthyl isomer
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
51.995035048691
|
jwh-210-2-ethylnaphthyl-isomer
|
|
JWHs cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetics smoking urinary urine serums JWH-210 JWH210 alkyindoles herbal blends |
51.995035048691
|
| 9001039 |
JWH 210 3-ethylnaphthyl isomer
New |
|
- |
≥98%
|
|
|
2011-11-30
|
74.802596125547
|
jwh-210-3-ethylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWHs JWH210 JWH-210 alkylindole herbal blends isomers ethyl chains naphthyl groups |
74.802596125547
|
| 9001040 |
JWH 210 5-ethylnaphthyl isomer
New |
|
- |
≥98%
|
|
|
2011-11-17
|
59.643329679629
|
jwh-210-5-ethylnaphthyl-isomer
|
|
cannabinoids cannabimimetics metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine serum alkylindoles herbal blends isomers JWH-210 JWH210 |
59.643329679629
|
| 9000771 |
JWH 210 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-08-10
|
44.869743788179
|
jwh-210-5-hydroxyindole-metabolite
|
|
JWH-210 JWH210 cannabinoids CBs cannabimimetic metabolites CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum |
44.869743788179
|
| 9001041 |
JWH 210 6-ethylnaphthyl isomer
New |
|
- |
≥98%
|
|
|
2012-01-31
|
206.657795692826
|
jwh-210-6-ethylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic smoking JWH210 JWH-210 JWHs isomers alkylindoles extracts herbal blends |
206.657795692826
|
| 9001042 |
JWH 210 7-ethylnaphthyl isomer
Exclusive New |
|
824960-64-7 |
≥98%
|
|
✓ |
2011-10-11
|
51.995035048691
|
jwh-210-7-ethylnaphthyl-isomer
|
JWH 234
|
JWHs cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine serums JWH-234 JWH234 JWH-210 JWH210 alkylindoles herbal blends |
51.995035048691
|
| 9001043 |
JWH 210 8-ethylnaphthyl isomer
New |
|
- |
≥95%
|
|
|
2011-11-04
|
53.097465114314
|
jwh-210-8-ethylnaphthyl-isomer
|
|
JWH210 JWH-210 cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum herbal alkylindole isomers naphthyl groups |
53.097465114314
|
| 10510 |
JWH 210-d9
New |
|
- |
≥99% deuterated product
|
|
|
2011-09-08
|
48.455738971633
|
jwh-210-d9
|
|
cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain |
48.455738971633
|
| 10940 |
JWH 210 N-(4-hydroxypentyl) metabolite
New |
|
- |
≥95%
|
|
|
2012-01-19
|
126.559825701640
|
jwh-210-n-4-hydroxypentyl-metabolite
|
|
cannabinoids CBs cannabimimetics metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWH210 JWH-210 JWHs alkylindoles liver |
126.559825701640
|
| 10941 |
JWH 210 N-(5-carboxypentyl) metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
51.668749500666
|
jwh-210-n-5-carboxypentyl-metabolite
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetics smoking urinary urine serums JWH-210 210 liver excreted |
51.668749500666
|
| 9000772 |
JWH 210 N-(5-hydroxypentyl) metabolite
New |
|
- |
≥98%
|
|
|
2011-11-04
|
51.094067501825
|
jwh-210-n-5-hydroxypentyl-metabolite
|
|
JWH 210 JWH210 cannabinoids CBs JWHs alkylindoles liver cannabimimetic metabolites CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum |
51.094067501825
|
| 11153 |
JWH 249
New |
|
864445-60-3 |
≥98%
|
|
|
2012-02-10
|
0E-12
|
jwh-249
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH249 JWH-249 JWHs central peripheral |
0E-12
|
| 13634 |
JWH 250
|
|
864445-43-2 |
≥98%
|
|
|
2010-01-14
|
76.881878954195
|
jwh-250
|
|
cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles cbs synthetic |
76.881878954195
|
| 9000766 |
JWH 250 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-20
|
35.722872928177
|
jwh-250-5-hydroxyindole-metabolite
|
|
JWH250 JWH-250 cannabinoids CBs cannabimimetics metabolite CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum |
35.722872928177
|
| 10661 |
JWH 250-d5
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-14
|
32.813926949452
|
jwh-250-d5
|
|
cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 |
32.813926949452
|
| 10939 |
JWH 250 N-(4-hydroxypentyl) metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-24
|
46.770100893042
|
jwh-250-n-4-hydroxypentyl-metabolite
|
|
JWHs JWH-250 JWH250 metabolites cannabinoids CB1 CB2 CBs herbal smoke smoking forensics receptors agonist cannabimimetic metabolite metabolism |
46.770100893042
|
| 10938 |
JWH 250 N-(5-carboxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-19
|
77.234958111501
|
jwh-250-n-5-carboxypentyl-metabolite
|
|
JWHs JWH-250 JWH250 metabolites forensics sciences urinary urine synthetics cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum |
77.234958111501
|
| 9000767 |
JWH 250 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-08-05
|
63.171820525698
|
jwh-250-n-5-hydroxypentyl-metabolite
|
|
JWH250 JWH-250 forensic sciences CBs cannabinoids JWHs cannabimimetics metabolites CB1 CB2 receptors agonists spices forensics synthetics smoking urinary urine serum |
63.171820525698
|
| 10578 |
JWH 251
|
|
864445-39-6 |
≥98%
|
|
|
2010-08-20
|
53.611618745255
|
jwh-251
|
|
cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics cannabinoids cbs synthetic |
53.611618745255
|
| 9001021 |
JWH 251 3-methylphenyl isomer
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
26.198148018386
|
jwh-251-3-methylphenyl-isomer
|
JWH 251 3-methyl isomer
|
cannabinoids receptors CB1 CB2 CBs WIN55212-2 WIN-552122 WIN-55212-2 WIN 55,2122 WIN 55,212-2 cannabimimetics urine forensic JWH-251 JWH251 adulterant |
26.198148018386
|
| 9001022 |
JWH 251 4-methylphenyl isomer
Exclusive New |
|
864445-41-0 |
≥98%
|
|
✓ |
2011-10-14
|
23.715191259040
|
jwh-251-4-methylphenyl-isomer
|
JWH 251 4-methyl isomer
|
JWH-251 JWH251 CBs cannabinoids receptors WIN 55212-2 WIN55212 WIN 55,212-2 WIN 55,2122 CB1 CB2 cannabimimetics urine forensics |
23.715191259040
|
| 10722 |
JWH 302
Exclusive |
|
864445-45-4 |
≥95%
|
|
✓ |
2011-03-04
|
77.296232569548
|
jwh-302
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH302 JWH-302 indoles central peripheral GTPγS binding |
77.296232569548
|
| 10797 |
JWH 307
New |
|
914458-26-7 |
≥96%
|
|
|
2011-12-15
|
96.786584949347
|
jwh-307
|
|
JWH307 JWH-307 cannabinoids CBs CB1 CB2 herbal smoking forensics receptors agonists JWHs cannabimimetic psychological neurological nuerology toxicological toxicology |
96.786584949347
|
| 10829 |
JWH 368
New |
|
914458-31-4 |
≥98%
|
|
|
2011-12-14
|
77.487867180509
|
jwh-368
|
|
JWH368 JWH-368 cannabinoids CBs CB1 CB2 herbal smoking forensics sciences receptors agonists cannabimimetic JWHs |
77.487867180509
|
| 10828 |
JWH 369
New |
|
914458-27-8 |
≥95%
|
|
|
2012-01-25
|
121.627138556643
|
jwh-369
|
|
JWH369 JWH-369 cannabinoids cannabimimetics CB1 CB2 CBs receptors agonists spices forensics synthetic central peripheral mouse research |
121.627138556643
|
| 10827 |
JWH 370
New |
|
914458-22-3 |
≥95%
|
|
|
2011-11-10
|
31.736608786711
|
jwh-370
|
|
JWH370 JWH-370 JWHs cannabinoids CB1 CB2 herbal smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH 018 JWH 18 JWH-018 JWH018 JWH073 JWH 73 JWH 073 JWH-073 analogs blends JWH-73 JWH73 JWH-18 JWH18 |
31.736608786711
|
| 13636 |
JWH 398
Exclusive |
|
- |
≥95%
|
|
✓ |
2010-10-22
|
73.228542786809
|
jwh-398
|
|
jwh398 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH-398 cbs synthetic |
73.228542786809
|
| 9001023 |
JWH 398 2-chloronaphthyl isomer
New |
|
- |
≥95%
|
|
|
2011-11-09
|
40.013311857133
|
jwh-398-2-chloronaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic herbal mixtures isomers chloro naphthyl JWH398 JWH-398 JWHs |
40.013311857133
|
| 9001024 |
JWH 398 3-chloronaphthyl isomer
New |
|
- |
≥98%
|
|
|
2012-01-11
|
109.267221717577
|
jwh-398-3-chloronaphthyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH398 JWH-398 JWHs isomers herbal mixtures chlorine naphthyl rings central peripheral |
109.267221717577
|
| 9001025 |
JWH 398 5-chloronaphthyl isomer
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-08-23
|
43.225616990506
|
jwh-398-5-chloronaphthyl-isomer
|
|
JWH398 JWH-398 forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics central peripheral |
43.225616990506
|
| 9001026 |
JWH 398 6-chloronaphthyl isomer
New |
|
- |
≥98%
|
|
|
2011-11-04
|
48.580300896462
|
jwh-398-6-chloronaphthyl-isomer
|
|
JWH398 JWH-398 cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic isomers herbal mixtures chloro groups naphthyl rings |
48.580300896462
|
| 9001027 |
JWH 398 7-chloronaphthyl isomer
New |
|
- |
≥98%
|
|
|
2011-11-16
|
52.001222523293
|
jwh-398-7-chloronaphthyl-isomer
|
|
cannabinoids cannabimimetics CBs CB1 CB2 receptor agonists spices forensics synthetic JWHs JWH398 JWH-398 isomers herbal chloro groups naphthyl rings |
52.001222523293
|
| 9001028 |
JWH 398 8-chloronaphthyl isomer
New |
|
- |
≥98%
|
|
|
2012-01-13
|
112.335403648117
|
jwh-398-8-chloronaphthyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic isomers herbal mixtures JWHs JWH-398 JWH398 central peripheral |
112.335403648117
|
| 10514 |
JWH 398-d9
Exclusive New |
|
- |
≥99% deuterated product
|
|
✓ |
2011-08-25
|
50.086297295345
|
jwh-398-d9
|
|
JWH398 JWH-398 standards cannabinoids CBs JWHs forensics sciences deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS |
50.086297295345
|
| 9000770 |
JWH 398 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-06
|
58.087841707496
|
jwh-398-n-5-hydroxypentyl-metabolite
|
|
JWH398 cannabinoids CBs JWH-398 forensic sciences JWHs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetics |
58.087841707496
|
| 13158 |
JZL 184
|
|
1101854-58-3 |
≥97%
|
|
|
2009-01-26
|
160.348107734806
|
jzl-184
|
|
2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoids pains analgesia MGL inhibitor JZL184 JZL-184 cannabinoids |
160.348107734806
|
| 13668 |
JZL 195
|
|
- |
≥98%
|
|
|
2010-02-10
|
120.234751381215
|
jzl-195
|
|
fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG cannabinoids inhibitors cbs sythetic Methylenedioxybenzenes
1,3-Dioxaindans 1,3 Dioxaindans 1,3-Dioxindans 1,3 Dioxindans Benzodioxoles |
120.234751381215
|
| 10640 |
KM 233
Exclusive |
|
628263-22-9 |
≥98%
|
|
✓ |
2011-07-07
|
35.974917127071
|
km-233
|
|
KM233 KM-233 CBs cannabinoids CB2 agonists recptors CB1 gliomas anti tumors cancers |
35.974917127071
|
| 10009280 |
L-759,633
|
|
174627-50-0 |
>98%
|
|
|
2007-09-13
|
35.046546961326
|
l-759-633
|
|
L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic |
35.046546961326
|
| 10008618 |
Lauric Acid Leelamide
|
|
- |
>98%
|
|
|
2006-09-05
|
0.520475138122
|
lauric-acid-leelamide
|
|
saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 12-carbons coconut nut oils COX-2 cyclooxygenase-2 cyclooxygenases expressions C:8-18 inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine leelamine cannabinoids cbs synthetic |
0.520475138122
|
| 10006148 |
Leelamine
|
|
1446-61-3 |
>98%
|
|
|
2006-05-10
|
0.520865561694
|
leelamine
|
Dehydroabietylamine
|
inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic |
0.520865561694
|
| 10008614 |
Leelamine (hydrochloride)
|
|
- |
≥98%
|
|
|
2006-05-10
|
0.419208103131
|
leelamine-hydrochloride
|
Dehydroabietylamine
|
inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic |
0.419208103131
|
| 13453 |
LH 21
|
|
611207-11-5 |
≥98%
|
|
|
2011-03-22
|
17.263738489871
|
lh-21
|
|
cannabimimetic CBs cannabinoids CB1 receptors antagonists pain weight gain obesity LH-21 LH21 central |
17.263738489871
|
| 10563 |
MDA 19
|
|
1048973-47-2 |
≥95%
|
|
|
2010-09-17
|
51.340761641673
|
mda-19
|
|
agonists cannabinoids CB2 CB1 pains 1104302-26-2 tactile allodynia paclitaxel spinal nerves ligation MDA-19 MDA19 CBs peripheral central MDAs central cannabinoids cbs synthetic cannabinoids Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Receptors, Epidermal Growth Factor-Urogastrone Receptor Transforming Growth Factor alpha Transforming Growth Factor alpha Receptor
Epidermal Growth Factor Receptor Kinase Receptor Epidermal Growth Factor Receptor erbB 1 Proto Oncogene Protein Receptor Urogastrone Urogastrone Receptor Receptor TGF alpha TGF-alpha Receptor c-erbB-1 Protein Proto-Oncogene Receptor EGF EGF Receptor
|
51.340761641673
|
| 10639 |
MDA 77
Exclusive |
|
1103774-21-5 |
≥98%
|
|
✓ |
2011-05-16
|
4.063591160221
|
mda-77
|
|
CB2 inverse agonists inflammation pain CB1 CBs cannabinoids peripheral MDA77 MDA-77 in vivo binds binding assay |
4.063591160221
|
| 10979 |
MDMA methylene homolog (hydrochloride)
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-22
|
34.462629087627
|
mdma-methylene-homolog-hydrochloride
|
3,4-Methylenedioxymethamphetamine methyl homolog
|
forensic sciences cannabinoids CBs pyrovalerones pentylones designer drugs forensics neuroscience psychoactive ecstasy HCl |
34.462629087627
|
| 10007704 |
N-(3-hydroxyphenyl)-Arachidonoyl amide
Exclusive |
|
183718-75-4 |
>98%
|
|
✓ |
2007-02-02
|
13.166132596685
|
n-3-hydroxyphenyl-arachidonoyl-amide
|
3-HPAA
|
neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA cannabinoids cbs synthetic |
13.166132596685
|
| 10007431 |
N-Arachidonoyl Dopamine-d8
|
|
- |
≥99% deuterated product
|
|
|
2005-08-10
|
10.737403314917
|
n-arachidonoyl-dopamine-d8
|
NADA-d8
|
deuterateds analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids ada cb1 cb2 analgesic arachidonoyl-dopamine neurochemistry neuroscience deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass 10007431 spectrometry cannabinoids cbs synthetic |
10.737403314917
|
| 10005455 |
N-Arachidonoyl-L-Serine
|
|
187224-29-9 |
>98%
|
|
|
2004-08-11
|
7.638297338021
|
n-arachidonoyl-l-serine
|
ARA-S
|
endocannabinoids antagonists cannabidiols neuroprotective neurotransmitters hypotensive effects antagonize antagonist neurochemistry neuroscience cannabinoids cbs synthetic |
7.638297338021
|
| 10005609 |
N-Oleoyl Taurine
Exclusive |
|
52514-04-2 |
≥98%
|
|
✓ |
2005-01-05
|
6.681187845304
|
n-oleoyl-taurine
|
|
endocannibinoids fatty amides oleamides taurines amino-acyls lipidomics profiling fatty acids neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
6.681187845304
|
| 10006803 |
O-1602
|
|
317321-41-8 |
>98%
|
|
|
2005-09-12
|
10.751519337016
|
o-1602
|
|
abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic |
10.751519337016
|
| 10006804 |
O-1821
|
|
35482-50-9 |
>97%
|
|
|
2005-09-12
|
18.792081031307
|
o-1821
|
|
abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic |
18.792081031307
|
| 10004914 |
O-1918
|
|
536697-79-7 |
>98%
|
|
|
2005-09-09
|
9.388121546961
|
o-1918
|
|
antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic |
9.388121546961
|
| 10009195 |
O-2545 (hydrochloride)
|
|
- |
>98%
|
|
|
2007-07-12
|
1.533701657459
|
o-2545-hydrochloride
|
|
cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic |
1.533701657459
|
| 10007823 |
Oleoyl Ethanolamide-d2
|
|
- |
≥99% deuterated product
|
|
|
2006-03-06
|
13.068480662984
|
oleoyl-ethanolamide-d2
|
OEA-d2; Oleic Acid Ethanolamide-d2
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
13.068480662984
|
| 9000552 |
Oleoyl Ethanolamide-d4
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-01-12
|
10.002320441988
|
oleoyl-ethanolamide-d4
|
Oleic Acid Ethanolamide-d4; OEA-d4
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic |
10.002320441988
|
| 10005459 |
Oleoyl Ethyl Amide
Exclusive |
|
85075-82-7 |
>98%
|
|
✓ |
2004-07-21
|
21.423348066299
|
oleoyl-ethyl-amide
|
N-Ethyloleamide; OEtA
|
endocannabinoids analogs FAAH fatty acid amide hydrolase analgesic inhibitors inhibitor inhibition acyl PEAase anxiolytic inhibits selective selectivity neuroscience neurochemistry cannabinoids cbs synthetic |
21.423348066299
|
| 10965 |
Palmitoleoyl Ethanolamide
|
|
94421-67-7 |
≥98%
|
|
|
2011-06-27
|
20.597642725599
|
palmitoleoyl-ethanolamide
|
POEA
|
cannabinoids endocannabinoids CBs N-acylethanolamines signalling N-acylethanolamides NAEs signaling receptors pain lipid-derived |
20.597642725599
|
| 13279 |
PF-3845
|
|
1196109-52-0 |
≥98%
|
|
|
2010-01-27
|
37.992885205648
|
pf-3845
|
|
fatty acids hydrolase FAAH N-acyl ethanolamines NAEs endocannabinoids N-arachidonoyl ethanolamine anandamide AEA inhibitors inhibits inflammation pain PF3845 PF 3845 cannabinoids cbs synthetic Antibodies Monoclonal
Monoclonal Antibodies |
37.992885205648
|
| 71655 |
PHOP
|
|
288862-83-9 |
>98%
|
|
|
2005-02-02
|
10.937995264403
|
phop
|
Phenyl hexanoyl oxazolopyridine; CAY10402
|
FAAH fatty acids amides hydrolases inhibits inhibitors inhibition cannabinoids CB1 CB2 hydrolysis hydrolyze CAY-10402 TGH triacylglycerols neurochemistry neuroscience cbs synthetic |
10.937995264403
|
| 10006973 |
Pravadoline
|
|
92623-83-1 |
≥98%
|
|
|
2011-02-08
|
49.107296654389
|
pravadoline
|
WIN 48,098
|
Anti-inflammatory analgesic COX inhibitors pain AAI NSAIDs inhibits inhibition prostaglandins PGs synthesis murine inhibited mouse cyclooxygnases opoid Indoles
receptors WIN48098 WIN-48098 WIN 48098 WIN-48,8098 |
49.107296654389
|
| 13621 |
Pristimerin
Exclusive |
|
1258-84-0 |
≥98%
|
|
✓ |
2010-03-08
|
42.875840568271
|
pristimerin
|
Celastrol methyl ester; NSC 99281
|
monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids cannabinoids cbs synthetic Triterpenes |
42.875840568271
|
| 12015 |
Prostaglandin D2-1-glyceryl ester
|
|
309260-52-4 |
>95% (as a 9:1 mixture of the 1- and 2-glyceryl esters)
|
|
|
2004-08-05
|
35.607513812154
|
prostaglandin-d2-1-glyceryl-ester
|
PGD2-1-glyceryl ester
|
endocannabinoids anandamides 2AG fatty acids porcine brain isomerase moiety cannabinoids cbs synthetic |
35.607513812154
|
| 10192 |
Prostaglandin D2 serinol amide
|
|
- |
>98%
|
|
|
2004-05-13
|
39.763292817680
|
prostaglandin-d2-serinol-amide
|
PGD2-SA
|
PGD2 vasodilation prostaglandins brain sleep platelets aggregation anandamides serinols amides cannabinoids AEA |
39.763292817680
|
| 10140 |
Prostaglandin E2-1-glyceryl ester
|
|
37497-47-5 |
>98% (as a 85:15 mixture of the 1- and 2-glyceryl esters)
|
|
|
|
48.040865561694
|
prostaglandin-e2-1-glyceryl-ester
|
PGE2-1-glyceryl ester
|
Prostaglandins PGE2-1-GE esters 2-AG 2-arachidonyl-glycerol metabolites COX-2 PGHS-2 cycloxygenases synthases PGE2-2-GE COX2 PGHS2 cannabinoids cbs synthetic |
48.040865561694
|
| 14012 |
Prostaglandin E2 Ethanolamide
Exclusive |
|
194935-38-1 |
>98%
|
|
✓ |
|
40.204841160221
|
prostaglandin-e2-ethanolamide
|
PGE2-EA; Dinoprostone Ethanolamide; Prostamide E2
|
anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides |
40.204841160221
|
| 10193 |
Prostaglandin E2 serinol amide
Exclusive |
|
- |
≥98%
|
|
✓ |
2004-03-03
|
36.258397790055
|
prostaglandin-e2-serinol-amide
|
PGE2-SA
|
PGE2SA cannabinoids agonists CB1 receptors analogs 2-glyceryl neurochemistry neuroscience |
36.258397790055
|
| 10139 |
Prostaglandin F2α-1-glyceryl ester
|
|
43042-79-1 |
>98% (as a 9:1 mixture of the 2- and 1-glyceryl esters)
|
|
|
|
16.060359116022
|
prostaglandin-f2-1-glyceryl-ester
|
PGF2α-1-glyceryl ester
|
Prostaglandins PGF2alpha-1-GE PGF2.alpha.-1-GE esters 2-AG 2-arachidonoyl-glycerol COX-2 metabolites cyclooxygenases PGHS-2 synthases PGHS2 COX2 PGF2alpha-2-GE PGF2.alpha.-2-GE PGFa-2-GE PGF2a-1-GE cannabinoids cbs synthetic |
16.060359116022
|
| 10194 |
Prostaglandin F2α serinol amide
|
|
- |
>98%
|
|
|
2004-02-23
|
13.622338858195
|
prostaglandin-f2-serinol-amide
|
PGF2α-SA
|
PGF2alphaSA PGF2.alpha.SA PGF2alpha-SA PGF2.alpha.-SA cannabinoids agonists CB1 recptors analogs 2-glyceryl esters amides neuroscience |
13.622338858195
|
| 10004281 |
R-1 Methanandamide Phosphate
|
|
- |
>98%
|
|
|
2004-08-20
|
17.891049723757
|
r-1-methanandamide-phosphate
|
R-1MAP; (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide Phosphate
|
endocannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors anandamides analogs agonists phosphates LPA lysophatidic acids neurochemistry neuroscience R1 cannabinoids cbs synthetic |
17.891049723757
|
| 10645 |
RCS-4
|
|
- |
≥98%
|
|
|
2010-11-24
|
127.480315197521
|
rcs-4
|
|
cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics CBs neurochemistry cannabinoids cbs synthetic |
127.480315197521
|
| 10865 |
RCS-4 2-methoxy isomer
|
|
- |
≥98%
|
|
|
2011-06-15
|
54.039667490549
|
rcs-4-2-methoxy-isomer
|
|
synthetic cannabinoids forensics receptors herbal spices incense JWH 250 JWH-250 JWH250 RCS4 RCS 4 analogs CB1 CB2 cannabimimetic indoles CBs |
54.039667490549
|
| 10866 |
RCS-4 3-methoxy isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-15
|
45.111948033066
|
rcs-4-3-methoxy-isomer
|
|
cannabinoids receptors JWH 018 CB1 CB2 CBs cannabimimetics forensics synthetic bath salts JWH-018 JWH018 |
45.111948033066
|
| 10798 |
RCS-4-C4 homolog
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-04-21
|
58.428009777551
|
rcs-4-c4-homolog
|
BTM-4; SR-19; OBT-199; E-4
|
cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetics smoking urinary urine serum JWH018 JWH 018 JWH-018 JWH18 BTM4 BTM 4 E4 E 4 OBT199 OBT 199 SR19 SR 19 |
58.428009777551
|
| 10513 |
RCS-4-d9
New |
|
- |
≥99% deuterated product
|
|
|
2011-09-12
|
44.447019892911
|
rcs-4-d9
|
|
cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS |
44.447019892911
|
| 10936 |
RCS-4 N-(4-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-29
|
38.576552595231
|
rcs-4-n-4-hydroxypentyl-metabolite
|
|
cannabinoids cannabimimetics metabolites CB1 CB2 CBs receptors agonists spices synthetic smoking urinary urine RCS4 RCS 4 JWHs glucuroconjugate forensics sciences neuroscience |
38.576552595231
|
| 10937 |
RCS-4 N-(5-carboxypentyl) metabolite
|
|
- |
≥98%
|
|
|
2011-06-28
|
44.108639866240
|
rcs-4-n-5-carboxypentyl-metabolite
|
|
RCS4 RCS 4 forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics |
44.108639866240
|
| 10935 |
RCS-4 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-17
|
45.618204419889
|
rcs-4-n-5-hydroxypentyl-metabolite
|
|
cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine RCS4 RCS 4 JWHs glucuroconjugate forensics sciences neuroscience |
45.618204419889
|
| 10636 |
RCS-8
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-11-02
|
110.680693566903
|
rcs-8
|
SR-18
|
cannabinoids receptors JWH 250 CB1 CB2 cannabimimetics forensics cannabinoids cbs synthetic Rabbit Aorta Contracting Substance
A2 Thromboxane Thromboxane A2 |
110.680693566903
|
| 10864 |
RCS-8 3-methoxy isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-13
|
31.955627180866
|
rcs-8-3-methoxy-isomer
|
|
RCS 8 RCS8 isomers CBs cannabinoids forensics sciences RCS-4 RCS4 cannabimimetics CB1 CB2 receptors agonists spices synthetics extracts cannabis herbal blends |
31.955627180866
|
| 10863 |
RCS-8 4-methoxy isomer
Exclusive |
|
- |
≥95%
|
|
✓ |
2011-07-13
|
38.326258650771
|
rcs-8-4-methoxy-isomer
|
|
RCS8 RCS 8 isomers forensics sciences RCS4 RCS-4 CBs cannabinoids cannabimimetics CB1 CB2 receptors agonists spices synthetics |
38.326258650771
|
| 9000484 |
Rimonabant
|
|
168273-06-1 |
≥98%
|
|
|
2009-06-17
|
70.164019337016
|
rimonabant
|
SR141716
|
SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory cbs sythetic |
70.164019337016
|
| 10899 |
(R)-(−)-JWH 073 N-(3-hydroxybutyl) metabolite
New |
|
- |
≥98%
|
|
|
2011-11-18
|
32.857078514426
|
-r-jwh-073-n-3-hydroxybutyl-metabolite
|
|
cannabinoids metabolites cannabimimetics forensics herbal blends spices adulterant enantiomer liver microsomes glucuronidate urine CBs JWHs JWH073 JWH-073 JWH 73 JWH73 JWH-73 |
32.857078514426
|
| 10898 |
(S)-(+)-JWH 073 N-(3-hydroxybutyl) metabolite
New |
|
- |
≥98%
|
|
|
2011-11-18
|
31.907078514426
|
-s-jwh-073-n-3-hydroxybutyl-metabolite
|
|
cannabinoids metabolites cannabimimetic forensics herbal blends spices CBs JWH073 JWH-073 JWH 73 JWH73 JWH-73 JWHs enantiomer liver microsomes glucuronidate urine |
31.907078514426
|
| 10009226 |
(±)-SLV 319
Exclusive |
|
362519-49-1 |
>98%
|
|
✓ |
2007-01-16
|
21.822596685082
|
-slv-319
|
|
CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands cannabinoids cbs synthetic |
21.822596685082
|
| 9000491 |
SR 144528
|
|
192703-06-3 |
≥98%
|
|
|
2009-08-05
|
71.692483118478
|
sr-144528
|
|
antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic |
71.692483118478
|
| 13830 |
Synthetic Cannabinoid HPLC Mixture I
|
|
- |
≥95% for each compound
|
|
|
2010-05-13
|
39.243082614455
|
synthetic-cannabinoid-hplc-mixture-i
|
|
cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic |
39.243082614455
|
| 13850 |
Synthetic Cannabinoid HPLC Mixture II
|
|
- |
≥95% for each compound
|
|
|
2010-12-21
|
39.551017802333
|
synthetic-cannabinoid-hplc-mixture-ii
|
|
cannabinoids CBs synthetics mixtures receptors agonists synthetic |
39.551017802333
|
| 11337 |
Synthetic Cannabinoid HPLC Mixture V (AM Series)
New |
|
- |
≥95% for each compound
|
|
|
2012-02-02
|
101.640890116636
|
synthetic-cannabinoid-hplc-mixture-v-am-series
|
|
AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 |
101.640890116636
|
| 13261 |
URB447
Exclusive |
|
1132922-57-6 |
≥98%
|
|
✓ |
2009-06-18
|
32.550309392265
|
urb447
|
|
CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 cannabinoids cbs synthetic |
32.550309392265
|
| 10046 |
URB597
|
|
546141-08-6 |
>98%
|
|
|
|
54.148442993470
|
urb597
|
|
FAAH fatty acid amide hydrolases inhibitors URB-597 anandamides lipids inhibition selective selectivity AEA inhibits hydrolysis hydrolyze arachidonoyl cannabinoids ethanolamides neuroscience neurochemistry |
54.148442993470
|
| 10007457 |
URB602
|
|
565460-15-3 |
>98%
|
|
|
2005-09-06
|
40.770787292817
|
urb602
|
|
monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry cannabinoids cbs synthetic |
40.770787292817
|
| 10007691 |
URB754
|
|
86672-58-4 |
>98%
|
|
|
2005-11-04
|
24.893955801105
|
urb754
|
|
neurochemistry neuroscience 2-AG 2-archidonoyl glyerol MGL monoacylglycerol lipase monoglyceride lipase endocannabinoids FAAH fatty acid amide hydrolase inhibitors inhibition inhibits monoglycerol MAGL neurochemistry cannabinoids |
24.893955801105
|
| 10674 |
URB937
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-03-08
|
17.586224677716
|
urb937
|
|
FAAH anandamide AEA inhibitors peripheral pain Cannabinoids
|
17.586224677716
|
| 10009023 |
(+)WIN 55212-2 (mesylate)
|
|
131543-23-2 |
>98%
|
|
|
2006-10-05
|
47.709641060716
|
-win-55212-2-mesylate
|
|
WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 cannabinoids cbs synthetic |
47.709641060716
|
| 10736 |
(±)WIN 55212 (mesylate)
New |
|
137795-17-6 |
≥98%
|
|
|
2012-01-11
|
110.382203395478
|
-win-55212-mesylate
|
|
cannabinoids CB1 CB2 receptors pain neuroscience agonists antagonists aminoalkylindole CBs enantiomers (+)WIN 55212-2 (-)WIN 55215-3 SR144528 SR-144528 SR 144528 racemic mesylate central peripheral |
110.382203395478
|
| 90215 |
α-Linolenoyl Ethanolamide
Exclusive |
|
57086-93-8 |
>98%
|
|
✓ |
|
10.168516179952
|
-linolenoyl-ethanolamide
|
|
cannabinoids neurotransmitters ethanolamides fatty acids CB alpha-linolenoyl .alpha.-linolenoyl cannabinergic neurochemistry neuroscience ethanolamines, cbs, synthetic |
10.168516179952
|